Arana Therapeutics
HOME

Archive News

2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

To download and view any of the documents listed below, click on the links. To view or print the Portable Document Format (PDF) files, you will need Adobe Acrobat Viewer installed on your system.

If you do not have the latest Adobe Viewer, please download it here before you attempt to open the desired file.

2004    
December 23, 2004 Notice of meeting and proxy form  
December 23, 2004 2004 Annual Report  
December 14, 2004 Domantis scientific update  
December 9, 2004 Peptech launches world-first pet contraceptive  
December 6, 2004 Return of Capital  
November 24, 2004 Peptech increases profile in the United Kingdom  
November 16, 2004 Peptech Financial Update  
November 15, 2004 Centocor Settlement  
November 11, 2004 Peptech Executive Chairman receives inaugural Mills Oration  
November 4, 2004 Peptech announces 2004 financial results  
October 26, 2004 Domantis announces co-development agreement  
October 20, 2004 Appointment of Lead Independent Director  
September 20, 2004 Investor Roadshow 2004  
September 13, 2004 Genera early discussions  
September 2, 2004 Peptech Update  
August 25, 2004 Suprelorin® Patent  
August 10, 2004 Board changes maintain momentum at Peptech
July 6, 2004 2004 Half Year Report  
June 17, 2004 Peptech joint venture bolstered by $2.1 million grant  
June 16, 2004 Domantis Founder & Director Knighted  
June 11, 2004 Peptech reaffirms commitment to dividend payment  
June 9, 2004 Termination of Peptech & Agenix merger  
May 31, 2004 Peptech and Agenix merger update  
May 18, 2004 Merger Update  
May 11, 2004 Announcement of Half Year Results-2004  
May 6, 2004 Clarification on contingent dividend  
April 29, 2004 Peptech Agenix merger to create Australia's premier Biotech company  
April 28, 2004 Trading Halt  
March 24, 2004 Strong Profit Forecast  
March 1, 2004 US Patent strengthens Domantis  
February 27, 2004 Executive Chairman's Address and AGM Presentations  
February 26, 2004 Peptech Arthritis Drug on Track  
January 13, 2004 Executive Chairman Presentation  
January 12, 2004 Executive Service Agreement